Flowvium

Pembanding Perusahaan

Analisis berdampingan posisi rantai pasokan, sinyal institusional, dan skor kesenjangan berita.

VS

Tingkat Kapitalisasi Pasar

MegavsTitan

Peran Rantai

leadervsleader

Skor Kesenjangan

N/AvsN/A

Aktivitas IB

N/AvsN/A

Perbandingan bauran pendapatan

NVO
NVDA
NVO

Novo Nordisk

NVO · pharma-biotech

leaderMega ($100B+)
Profil lengkap

Tentang

Novo Nordisk is the global leader in diabetes care and has become a GLP-1 giant with Ozempic and Wegovy. The obesity-drug revolution has made it Europe's most valuable company. Its near-monopoly on injectable semaglutide positions it at the center of the $100B+ weight-loss drug market.

Didirikan

1923

Karyawan

64,000+

Kantor Pusat

Bagsvaerd, Denmark

Pendapatan

$42.6B

GLP-1 Diabetes (Ozempic, Rybelsus)42%
Obesity (Wegovy)25%
Insulin20%
Rare Disease & Other13%

Sinyal kesenjangan berita

Tidak ada data kesenjangan berita untuk ticker ini.

Sinyal institusional

Tidak ada sinyal 13F yang tercatat untuk ticker ini.

Hubungan kunci

LLY· Eli Lilly and Company
competitor
PFE· Pfizer Inc.
competitor
NVD

NVIDIA Corporation

NVDA · semiconductors

leaderTitan ($1T+)
Profil lengkap

Tentang

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

Didirikan

1993

Karyawan

32,000+

Kantor Pusat

Santa Clara, California, USA

Pendapatan

$130.5B

Data Center78%
Gaming12%
Professional Visualization4%
Automotive & Robotics4%
OEM & Other2%

Sinyal kesenjangan berita

Tidak ada data kesenjangan berita untuk ticker ini.

Sinyal institusional

Tidak ada sinyal 13F yang tercatat untuk ticker ini.

Hubungan kunci

TSM· Taiwan Semiconductor Manufacturing Company
supplier
005930.KS· Samsung Electronics
supplier
000660.KS· SK Hynix
supplier
MU· Micron Technology
supplier
MSFT· Microsoft Corporation
customer